The global market for intraosseous infusion devices is on a remarkable upward trajectory, with market valuation expected to surge from USD 4.4 billion in 2023 to a staggering USD 8.6 billion by 2033. This robust growth is forecasted to be driven by an impressive Compound Annual Growth Rate (CAGR) of 6.9%, signaling a substantial increase in the adoption of these critical devices across the world.
Intraosseous infusion devices are becoming increasingly vital in the global healthcare landscape, particularly in emergency medical scenarios. Recent market analysis reveals that demand for these devices is fueled by advancements in healthcare technologies and a growing emphasis on emergency medical care. The rising need for rapid, effective vascular access in life-threatening situations has underscored the value of intraosseous infusion devices in delivering quick and reliable methods of administering fluids and medications, especially when traditional intravenous access proves difficult or time-consuming.
“Intraosseous infusion devices are transforming the way we approach emergency care. These devices play a crucial role in trauma, cardiac arrest, and severe dehydration cases where immediate vascular access can mean the difference between life and death,” said a leading industry expert. “As the frequency of such medical emergencies grows and healthcare systems worldwide focus on improving emergency response, the demand for intraosseous infusion solutions is expected to continue its upward trajectory.”
Key to the market’s expansion is the increasing use of intraosseous infusion devices in critical medical situations. With healthcare infrastructures improving globally and technology advancing rapidly, intraosseous infusion devices are being integrated into emergency protocols, ensuring enhanced patient outcomes and streamlined medical responses.
The growth potential of this market has not gone unnoticed by stakeholders, who are ramping up investments in research and development. Continuous innovation in intraosseous infusion technology is expected to unlock new opportunities for growth, further solidifying the critical role of these devices in modern healthcare.
As the market for intraosseous infusion devices continues to evolve, it is clear that these solutions will remain indispensable in the quest to provide efficient, life-saving care in emergency settings.
Key Takeaways from Intraosseous Infusion Devices Market Study:
- By product, EZ-IO holds the maximum share of 20% in the market in 2021, expanding at 6.4% CAGR during the forecast period.
- By route of administration, the sternum segment will account for 30.8% of the market share in 2021, indicating the highest demand.
- By technology, the automatic segment will account for more than 50.8% of the market share in 2021.
- By end user, EMS centers and Hospitals together account for more than 60% of the market share in 2021.
“Increasing demand in improving standards of pre-hospital emergency care settings will boost the intraosseous infusion devices market over the decade. Growth will continue as market players focus on automation to improve the overall quality of devices,” says a FMI Analyst
Who is winning?
Some of the leading companies operating in the intraosseous infusion device market are focusing on product launch, collaboration, and partnership strategies.
- Cook Medical: Every medical profession we offer has two common threads: patients who want to be healthy and clinicians who desire more user-friendly tools. As a result, we devote significant resources to designing, manufacturing, and delivering a differentiated range of minimally invasive medical devices to healthcare systems worldwide.
- Becton Dickinson and Company: With a product line that fulfils the needs of patients, we want to increase physician satisfaction while also assisting hospitals and surgery centres in improving results and lowering expenses. BD has refined surgical instruments and led to improved results for more than a century. with a substantial portfolio and a track record of supplying high-quality items
The key market players covered by FMI include:
- Pyng Medical Corp.
- Biopsybell
- Cook Medical Incorporated
- PAVmed
- PerSys Medical
- Aero Healthcare
- Teleflex, Inc.
- Becton Dickinson and Company
- SAM Medical
- Cardinal Health, Inc
Intraosseous Infusion Devices – Market by Category:
Product:
- B.I.G
- FAST1
- EZ-IO
- FASTR
- IO Needles
- Others
By Route of Administration:
- Sternum
- Distal & Proximal Tibia
- Distal Femur
- Calcaneus
- Head of Humerus
By Technology:
- Manual
- Automatic
- Impact Driven
- Power Drill
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube